Phreesia Continues To Stay Positive On The Business Growth

andreswd Summary Following my coverage of Phreesia (NYSE:PHR), for which I reiterated a buy rating given that fundamentals remained sound and that PHR could continue to see pricing tailwinds ahead, this post is to provide an update on my thoughts on the business and stock. I reiterate my buy rating for PHR as I see the business continuing to grow revenue at 20+% and the adjusted EBITDA margin inflecting upwards as the business scales. The new product rolled out to target post-script engagements should also ...